Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Six existing drugs may help block virus entry in COVID-19.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Cepharanthine could be a strong antiviral against COVID-19.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Polynucleotides effectively promote hair regrowth in androgenetic alopecia without serious side effects.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.